Let's explore how GLP-1 and PMDD relate, and how Fitty can support your health goals during these challenging times
Support access: The platform includes asynchronous provider messaging, patient support channels, dosage review options, and prescription switching as part of its support structure, subject to the patient's active plan and provider review
Clinical trials show tirzepatide may produce greater weight loss than semaglutide alone in some patient populations, and the PlexusDx Precision Peptide Genetic Test can help identify whether a patient's genetic profile favors monotherapy or dual-compound treatment
Anyone with type 2 diabetes or who has been trying to lose weight has probably heard of glucagon-like peptide-1 (GLP-1) medications
The hormonal mechanism of tirzepatide reduces the mental preoccupation with food that many people with obesity experience
This bridges decades of population-level clinical trials with your individual biology, helping PlexusDx optimize whether you benefit most from semaglutide injection ($189/mo), tirzepatide ($289/mo), or dual-pathway optionspersonalizing treatment that earlier patients could not access
